Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1260056

High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study


Campbell, Matthew D.; Babic, Drazen; Bolcina, Uros; Smirčić-Duvnjak, Lea; Tankova, Tsvetalina; Mitrakou, Asimina; Kempler, Peter; Janez, Andrej
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study // Acta Diabetologica, 56 (2019), 9; 1045-1049 doi:10.1007/s00592-019-01346-1 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1260056 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study

Autori
Campbell, Matthew D. ; Babic, Drazen ; Bolcina, Uros ; Smirčić-Duvnjak, Lea ; Tankova, Tsvetalina ; Mitrakou, Asimina ; Kempler, Peter ; Janez, Andrej

Izvornik
Acta Diabetologica (0940-5429) 56 (2019), 9; 1045-1049

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Clinical inertia ; Insulin therapy initiation ; Type 2 diabetes mellitus.

Sažetak
Aims: Little is known regarding initiation of insulin therapy in type 2 diabetes (T2D) in Central and South-Eastern European countries. Therefore, we conducted a survey to characterise the prescribing practices of specialist diabetes healthcare professionals in this region and assessed factors that influence clinical decision- making regarding insulin initiation in T2D. Methods: A cross-sectional survey sampled 211 specialist diabetes healthcare prescribers from five Central and South-Eastern European countries (Bulgaria, Croatia, Greece, Hungary, and Slovenia). A structured questionnaire was developed which surveyed current clinical practices and influencing factors, barriers to insulin initiation, and combination therapy prescribing preferences. Result: Only 9.4% (20 of out of 211 respondents) of healthcare professionals would initiate insulin therapy in T2D patients at the recommended HbA1c threshold of 7-7.9% [53-63 mmol/mol]. Large regional differences were evident in insulin initiation thresholds (≥ 9.0% [≥ 75 mmol/mol]: Bulgaria 80.8% vs. Slovenia 13.3%). Psychological distress was recorded as the major barrier to insulin initiation. Health insurance regulations were ranked more important than personal clinical experience and clinical guidelines in clinical decision-making. Information from peers was more influential than manufacturer information, clinical experience, and continuous medical education, respectively, for insulin initiation. Conclusions: Despite large regional variation, there is widespread delay of insulin initiation from specialist diabetes healthcare professionals in Central and South-Eastern Europe.

Izvorni jezik
Engleski



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Dražen Babić (autor)

Avatar Url Lea Smirčić-Duvnjak (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Campbell, Matthew D.; Babic, Drazen; Bolcina, Uros; Smirčić-Duvnjak, Lea; Tankova, Tsvetalina; Mitrakou, Asimina; Kempler, Peter; Janez, Andrej
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study // Acta Diabetologica, 56 (2019), 9; 1045-1049 doi:10.1007/s00592-019-01346-1 (međunarodna recenzija, članak, znanstveni)
Campbell, M., Babic, D., Bolcina, U., Smirčić-Duvnjak, L., Tankova, T., Mitrakou, A., Kempler, P. & Janez, A. (2019) High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study. Acta Diabetologica, 56 (9), 1045-1049 doi:10.1007/s00592-019-01346-1.
@article{article, author = {Campbell, Matthew D. and Babic, Drazen and Bolcina, Uros and Smir\v{c}i\'{c}-Duvnjak, Lea and Tankova, Tsvetalina and Mitrakou, Asimina and Kempler, Peter and Janez, Andrej}, year = {2019}, pages = {1045-1049}, DOI = {10.1007/s00592-019-01346-1}, keywords = {Clinical inertia, Insulin therapy initiation, Type 2 diabetes mellitus.}, journal = {Acta Diabetologica}, doi = {10.1007/s00592-019-01346-1}, volume = {56}, number = {9}, issn = {0940-5429}, title = {High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study}, keyword = {Clinical inertia, Insulin therapy initiation, Type 2 diabetes mellitus.} }
@article{article, author = {Campbell, Matthew D. and Babic, Drazen and Bolcina, Uros and Smir\v{c}i\'{c}-Duvnjak, Lea and Tankova, Tsvetalina and Mitrakou, Asimina and Kempler, Peter and Janez, Andrej}, year = {2019}, pages = {1045-1049}, DOI = {10.1007/s00592-019-01346-1}, keywords = {Clinical inertia, Insulin therapy initiation, Type 2 diabetes mellitus.}, journal = {Acta Diabetologica}, doi = {10.1007/s00592-019-01346-1}, volume = {56}, number = {9}, issn = {0940-5429}, title = {High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study}, keyword = {Clinical inertia, Insulin therapy initiation, Type 2 diabetes mellitus.} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font